Paper41280653
Recent progress of nanomaterials for diagnosis and treatment of rejection in heart transplantation.
Li G and 8 others. Front Bioeng Biotechnol, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Recent progress of nanomaterials for diagnosis and treatment of rejection in heart transplantation. Papers, record 41280653. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41280653
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Recent progress of nanomaterials for diagnosis and treatment of rejection in heart transplantation.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References154
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31343564 | Ultrasound Molecular Imaging of Lymphocyte-endothelium Adhesion Cascade in Acute Cellular Rejection of Cardiac Allografts. | Transplantation | 2019 | https://conductscience.org/library/papers/31343564 | PubMed |
| 2 | 39842736 | Tannic acid-modified FK506-loaded nanoparticles targeting lymph nodes for acute heart transplant rejection treatment. | Int J Pharm | 2025 | https://conductscience.org/library/papers/39842736 | PubMed |
| 3 | 32187839 | Safety-by-Design of Metal Oxide Nanoparticles Based on the Regulation of their Energy Edges. | Small | 2020 | https://conductscience.org/library/papers/32187839 | PubMed |
| 4 | 27979573 | Extracellular Vesicles: Unique Intercellular Delivery Vehicles. | Trends Cell Biol | 2017 | https://conductscience.org/library/papers/27979573 | PubMed |
| 5 | 33506680 | Noninvasive Radionuclide Molecular Imaging of the CD4-Positive T Lymphocytes in Acute Cardiac Rejection. | Mol Pharm | 2021 | https://conductscience.org/library/papers/33506680 | PubMed |
| 6 | 36209580 | Multifunctional nanoprobes for macrophage imaging. | Biomaterials | 2022 | https://conductscience.org/library/papers/36209580 | PubMed |
| 7 | 39586401 | Graft-derived extracellular vesicles transport miRNAs to modulate macrophage polarization after heart transplantation. | Am J Transplant | 2025 | https://conductscience.org/library/papers/39586401 | PubMed |
| 8 | 40847355 | Ultrasound molecular imaging of M2 macrophages for early detection of chronic rejection in heart transplantation. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/40847355 | PubMed |
| 9 | 31286573 | Integrating Artificial Intelligence and Nanotechnology for Precision Cancer Medicine. | Adv Mater | 2020 | https://conductscience.org/library/papers/31286573 | PubMed |
| 10 | 30413362 | Inhibiting Inflammation with Myeloid Cell-Specific Nanobiologics Promotes Organ Transplant Acceptance. | Immunity | 2018 | https://conductscience.org/library/papers/30413362 | PubMed |
| 11 | 40197267 | Macrophage membrane coated nanoscale coordination polymers promote graft survival in allogeneic transplantation. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/40197267 | PubMed |
| 12 | 37314368 | Surface Engineering of Nanoparticles toward Cancer Theranostics. | Acc Chem Res | 2023 | https://conductscience.org/library/papers/37314368 | PubMed |
| 13 | 35358806 | Nanoparticles: From synthesis to applications and beyond. | Adv Colloid Interface Sci | 2022 | https://conductscience.org/library/papers/35358806 | PubMed |
| 14 | 34262152 | Nanotherapeutics for cardiovascular disease. | Nat Rev Cardiol | 2021 | https://conductscience.org/library/papers/34262152 | PubMed |
| 15 | 20185042 | Ultrasound-microbubble-mediated intercellular adhesion molecule-1 small interfering ribonucleic acid transfection attenuates neointimal formation after arterial injury in mice. | J Am Coll Cardiol | 2010 | https://conductscience.org/library/papers/20185042 | PubMed |
| 16 | 24097421 | Magnetic resonance imaging investigation of macrophages in acute cardiac allograft rejection after heart transplantation. | Circ Cardiovasc Imaging | 2013 | https://conductscience.org/library/papers/24097421 | PubMed |
| 17 | 23921443 | Ultrasound molecular imaging of acute cellular cardiac allograft rejection in rat with T-cell-specific nanobubbles. | Transplantation | 2013 | https://conductscience.org/library/papers/23921443 | PubMed |
| 18 | 33363540 | Damage-Associated Molecular Patterns in Myocardial Infarction and Heart Transplantation: The Road to Translational Success. | Front Immunol | 2020 | https://conductscience.org/library/papers/33363540 | PubMed |
| 19 | 39734479 | Exosomes derived from microRNA-540-3p overexpressing mesenchymal stem cells promote immune tolerance via the CD74/nuclear factor-kappaB pathway in cardiac allograft. | World J Stem Cells | 2024 | https://conductscience.org/library/papers/39734479 | PubMed |
| 20 | 32548962 | Antagomir-155 Attenuates Acute Cardiac Rejection Using Ultrasound Targeted Microbubbles Destruction. | Adv Healthc Mater | 2020 | https://conductscience.org/library/papers/32548962 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41280653
GET https://conductscience.org/api/papers/v1/41280653/references?page=2